Infusion therapy devices market seen reaching $21.82 billion by 2030

The Business Research Company projects the global infusion therapy devices market will rise from $14.74 billion in 2026 to $21.82 billion by 2030, driven by chronic disease growth, home-based care and smart hospital spending. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Infusion therapy devices are becoming more important as hospitals, home care providers and clinicians need more precise ways to deliver fluids, drugs, nutrients and blood products. - The market’s growth signals rising demand for connected, safer and more portable treatment systems as chronic disease care expands.

What happened: - The Business Research Company released a 2026 market report on the global infusion therapy devices sector. - The report estimates the market will grow from $13.33 billion in 2025 to $14.74 billion in 2026. - The report forecasts the market will reach $21.82 billion by 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the market report is available. - A full report version is also available.

The details: - Infusion therapy devices are used to administer fluids, medications, nutrients or blood products directly into a patient’s bloodstream. - The report says recent growth has been driven by chronic illness, more hospital admissions requiring infusion treatment, larger oncology and diabetes patient populations, broader intravenous drug delivery use and better access to infusion devices. - The forecast to 2030 assumes stronger demand for home healthcare, connected medical technology, personalized medicine delivery, medication-error reduction and smart hospital infrastructure. - Expected growth trends include smart infusion pumps, portable and ambulatory devices, dose error reduction systems, home-based infusion therapies and better patient safety monitoring. - North America was the largest market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Between the lines: - The report points to a shift from basic infusion hardware toward connected systems that support safety, monitoring and care outside the hospital. - Chronic disease management remains the main demand engine, which suggests the market is tied closely to long-term treatment needs rather than one-time procedures. - The regional outlook implies mature markets will continue to lead in revenue, while faster healthcare investment in Asia-Pacific could reshape growth by volume.

What's next: - Market growth is likely to be shaped by adoption of smart pumps, ambulatory devices and home infusion models. - Continued investment in hospital technology and patient safety systems should keep pressure on suppliers to add connectivity and error-reduction features. - The report’s broader forecasting tools and updated graphics are aimed at helping buyers and investors track where demand is strongest next.

The bottom line: - Infusion therapy devices are moving from a clinical necessity to a technology-driven growth market, with chronic disease, home care and smart hospitals setting the pace.